Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy

OBJECTIVE: This study set out to explore the regulatory mechanism of miR-130a-5p in cisplatin (DDP)-resistant gastric cancer (GC) cells. MATERIALS AND METHODS: Forty cases of GC and paracancerous tissues were collected, and the miR-130a-5p and CCL22 levels were detected by qRT-PCR. DDP-resistant cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Qing-Liang, Li, Kai-Chun, Wang, Lei, Gu, Xiang-Lian, Song, Ren-Jie, Lu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263884/
https://www.ncbi.nlm.nih.gov/pubmed/32547223
http://dx.doi.org/10.2147/CMAR.S249738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263884/
https://www.ncbi.nlm.nih.gov/pubmed/32547223
http://dx.doi.org/10.2147/CMAR.S249738

Ejemplares similares